Intensive Antiplatelet Therapy and Risk of Recurrent Stroke
Efficacy of triple antiplatelet therapy compared with current guideline-based therapy for the prevention of recurrent stroke was evaluated in the TARDIS trial.
International Stroke Conference 2017
Vagus Nerve Stimulation May Improve Stroke Recovery
More patients receiving VNS experienced enhanced arm movement over a 90-day period.
Oral Anticoagulation After ICH: Risks and Outcomes
Restarting anticoagulation after both nonlobar and lobar ICH was associated with decreased mortality.
Is There Gender Bias in Stroke Care?
Men were more likely than women to be treated with IV tPA within 30 minutes of arrival at a hospital.
Medical Complications After ICH: Changes in the Last Decade
As more patients survive ICH, emphasis is slowly shifting from survival to improving ICH-related morbidity and optimization of functional recovery.
Contact Aspiration vs Stent Retriever in Acute Ischemic Stroke
The results provide good evidence for the use of contact aspiration in ischemic stroke.
Cilostazol Helps Prevent Secondary Stroke But Not Without Risk
Optimal antiplatelet treatment has yet to be determined for stroke survivors with prior intracerebral hemorrhage.
Comorbid Headache, Stroke Common in Pediatric Patients
The co-presentation of headache at stroke onset in children may provide clues to underlying pathophysiologic mechanisms.
Acute Stroke Risk Elevated in Patients With Psychiatric Illness
Psychological distress may cause changes within cells that trigger inflammation and oxidative stress, both of which are believed to increase stroke risk.
Time to Alteplase Treatment Affected by Hospital Delays, Medical Conditions
Delays related to the determination of treatment eligibility increased door-to-needle times by more than 30 minutes compared with patients with no delays.
Want to read more?
Please login or register first to view this content.
Next post in International Stroke Conference 2017
